Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3711_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
32 Мб
Скачать
Glycoprotein
Degenerated
Degenerated
lamellae
normal appearing
3 Pathophysiology ofAscending Aortic Aneurysm andDissection
https://t.me/med1917
Fig. 3.7 Ascending
aneurysm formation. Most aneurysms develop over time and are associated with microstructural changes in the aortic media. In normal elastic lamellae under normal blood pressure conditions, collagen bers are slack, and elastic bers carry the load. The normal microstructure includes elastic ber extensions between the loaded lamellae and SMCs to provide mechanosensation and mechanotransduction. With inappropriate signaling and uncoupling of SMCs, there are matrix degradation, apoptosis of SMCs, and elastolysis. An intermediate stage exists where elastic lamellae may persist without SMCs. The ultimate result is that areas of the media lose functional elastic bers and have no elastic recoil. Collagen bers are tensioned, and the aortic diameter necessarily increases, and the wall thins. Tears that may lead to dissection occur in the more normal-appearing areas such as on the lower left
Tears occur in
SMCs with
elastic
extensions
Elastic lamellae
areas
Collagen bundles not under tension
load born by elastic
SMC
pool
37
elastin
Collagen bundles now load bearing
Smooth lamellae
with no SMCs
Loss of elastic extensions
7. Impairment in canonical TGFβ signaling is a cause of
8. Loss of mechanosensation or mechanotransduction by
9. The nding of microscopic transverse tears in the media
A large proportion of ascending aneurysms have a rec­ognizable genetic defect that promotes this process. Those defects associated with preservation of robust collagen bers are likely to present later in life with larger aneurysms but remain subject to the mechanical features of the degenerated 6cm aorta. This group may represent the majority of patients with aneurysms (Fig.3.7).
aneurysms. Upregulation of noncanonical TGFβ signal­ing, possibly in response to decient canonical path­ways, may be the driving factor.
SMCs with loss of elastic ber extensions to elastic lamellae likely plays a major role in the pathogenesis of both aneurysm and dissection.
of “normal” aortas may indicate the presence of a sub­clinical defect but also illustrates the dangers of uncon­trolled hypertension where such a tear could provide a
nidus for dissection. Aneurysm and dissection are both diseases of hypertension.
10. Accurate prediction of rupture and dissection requires knowledge of the expected micromechanical properties of a patient’s aorta as well as a precise morphologic characterization. High-resolution, dynamic imaging combined with genomic testing could result in improved prediction methods.
Syndromic andNonsyndromic Ascending Aortic Disease
Syndromes of thoracic aneurysms and dissection, known as TAAD, have a strong genetic component and, when inherited by more than one member of a family, are often referred to as familial TAAD (FTAAD). Descending thoracic aortic pathol­ogy is associated with hypertension and known risk factors for atherosclerosis. While these risk factors may play some
38
T. E. Gaines and L. B. Grimsley
https://t.me/med1917
Table 3.1 Catalog of genetic syndromes involving the ascending aorta
Gene Locus Altered protein Syndrome Inheritance
ECM proteins
FBN1 15q21.1 Fibrillin-1 Marfan syndrome AD EFEMP2 11q13.1 Fibulin-4 Cutis laxa type IB AR ELN 7q11.23 Elastin Cutis laxa AD COL3A1 2q32.2 Collagen 3 alpha-1 Ehlers-Danlos syndrome type 4 AD COL4A1 13q34 Collagen 4 alpha-1 Hereditary angiopathy with nephropathy, aneurysms,
COL 4A5 PLOD1 1p36.22 Lysyl hydroxylase 1 Ehlers-Danlos syndrome type 6 AR PLOD3 7q22 Lysyl hydroxylase 3 Bone fragility, contractures, arterial rupture, deafness AR LOX 5q23.1 Lysyl oxidase FTAAD, (AAT10) AD MFAP5 12p13.31 Microbrillar associated protein 5
TGFβ pathway proteins
TGFBR1 9q22.33 Transforming growth factor beta
TGFBR2 3q24.1 Transforming growth factor beta
TGFB2 1q41 Transforming growth factor beta 2 Loeys-Dietz syndrome type 4 AD TGFB3 14q24.3 Transforming growth factor beta 3 Loeys-Dietz syndrome type 5 AD SMAD2 18q21.1 SMAD family 2 Aortic/peripheral arterial aneurysm/dissection SMAD3 15q22.33 SMAD family 3 Aneurysms-osteoarthritis syndrome/Loeys-Dietz
SMAD4 18q21.2 SMAD family 4 Juvenile polyposis/hereditary hemorrhagic telangiectasia AD SKI 1p36.33-p36.32 SKI sarcoma oncogene homolog Shprintzen-Goldberg syndrome AD
Smooth muscle contractile unit proteins
ACTA2 10q23.3 Smooth muscle cell alpha actin FTAAD (AAT6) Moyamoya disease AD MYH11 16p13.11 Smooth muscle cell myosin heavy
FLNA Xq28 Filamin A Periventricular nodular heterotopia X-linked
MYLK 3q21.1 Myosin light chain kinase FTAAD (AAT7) AD PRKG1 10q11.2 cGMP-dependent protein kinase
Neural crest migration
NOTCH1 9q34.3 Notch1 Bicuspid aortic valve with aneurysm AD
Undened defect
Data from: Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). Updated October 19, 2017. World Wide Web URL:
Xq22.3 Collagen 4 alpha-5 X-linked Alport syndrome X-linked
(MAGP-2)
receptor 1
receptor 2
chain
type 1
11q23.3–24 FTAAD (AAT1) 5q13-q14 FTAAD (AAT2)
muscle cramps (HANAC)
FTAAD, (AAT9) AD
Loeys-Dietz syndrome type 1, (AAT5), AD
Loeys-Dietz syndrome type 2, (AAT3) AD
syndrome type 3
FTAAD (AAT4) AD
FTAAD (AAT8) AD
https://omim.org/
AD
AD
dominant
role in the development of ascending aortic pathology, genetic factors appear to play a larger role. The genetic aspects of ascending aortic pathology can be categorized as syndromic and nonsyndromic. The term syndromic refers to phenotypes of the genetic defect that involve other organ sys­tems as well as the cardiovascular system and occur in recog­nizable patterns. Nonsyndromic defects appear to be primarily manifested within the aorta or occur as sporadic cases. Syndromic aortic defects are more easily recognizable clinically and include Marfan syndrome (MFS), Loeys-Dietz syndrome (LDS), Ehlers-Danlos syndrome type 4 (EDS-IV), Weill-Marchesani syndrome (WMS), aneurysm arthritis syndrome, arterial tortuosity, and cutis laxa [91] (Table3.1).
Marfan syndrome is an autosomal dominant disorder of connective tissues most commonly due to a mutation in the FBN1 gene encoding for the protein brillin 1. Penetrance is 100%, but the phenotype can be variable. The phenotype typically consists of skeletal abnormalities such as pectus excavatum or carinatum, arachnodactyly, scoliosis, increased joint laxity, mitral valve prolapse, ectopia lentis, striae of the skin, and dural ectasia. The most deadly phenotypic manifes­tation of this disorder is found in the dilation and degenera­tive changes of the aortic root and ascending aorta, which can lead to dissection and rupture.
Fibrillin mutations also are associated with the Weill­Marchesani syndrome. While brillin mutations in MFS
3 Pathophysiology ofAscending Aortic Aneurysm andDissection
https://t.me/med1917
39
cause tall stature, arachnodactyly, hypermobile joints, and hypomuscularity, the opposite phenotype appears in WMS [49]. WMS patients have short stature, brachydactyly, stiff joints, ectopia lentis, myopia, glaucoma, tight skin, hyper­muscularity, and heart defects. WMS can be inherited in an autosomal dominant or recessive fashion. The recessive type has been linked to a gene on chromosome 19. ADAMTS10, a zinc-dependent protease, has been linked to autosomal recessive forms of WMS.The autosomal dominant form has been linked to the FBN1 gene. Cardiovascular defects that affect people with WMS include mitral valve prolapse, aortic and pulmonary valve stenosis, ventricular septal defects, QTc prolongation, and ascending aortic dilation [91, 92].
Loeys-Dietz syndrome is associated primarily with TGFβ signaling pathways. Patients with LDS inherit the phenotype in an autosomal dominant pattern and have chest wall defor­mities such as pectus carinatum or pectus excavatum, a high arched or cleft palate, pes planus, clubfoot, scoliosis, bid uvula, hypertelorism, widespread arterial tortuosity, and spe­cically aortic root aneurysms. They are similar in pheno­type to MFS patients, except that the arteriopathy that occurs in LDS seems to be more widespread and occurs in periph­eral arteries as well as the aorta. There are ve types of Loeys-Dietz syndrome. Type 1 is caused by mutations in the TGFBR1 gene, which encodes for the TGFβ receptor 1. Type 2 is caused by mutations in TGFBR2 [93]. Type 2 patients tend to have joint laxity, easy bruising, velvety skin, diffuse arterial aneurysms and dissections, and near translucent skin [94]. Type 3 mutations are caused by mutations of the SMAD3 gene. Type 4 LDS is caused by a mutation involving the TGFβ 2 ligand [93]. Type 5 LDS is caused by a mutation in the gene encoding for TGFβ 3 ligand. As with MFS, the greatest clinical danger with LDS is the presence of severe cardiovascular defects. LDS is associated with aortic dissec­tion, occasionally with no warning and no apparent dilation. The mean age of rst vascular events tends to occur at a younger age, at around 30years old.
Vascular Ehlers-Danlos syndrome type 4 (EDS-IV) is a connective tissue disorder that affects type 3 collagen. There are more than ten types of EDS, each with a different pheno­type. Most phenotypes share similarities in regard to joint hypermobility, cutaneous fragility, and hyperextensibility. Type 4 is generally an autosomal dominant inherited disor­der although autosomal recessive forms have also been described. There is signicant phenotypic overlap between LDS and EDS-IV.EDS-IV patients are often short and have translucent skin. Their joint hyperextensibility is less pro­nounced than other EDS types. In addition to frequent arte­rial rupture, EDS-IV patients are found to have valvular prolapse and frequent spontaneous pneumothorax. Type 3 collagen is decient in EDS type 4 due to a defect in the COL3A1 gene. This causes markedly increased fragility of connective tissues that may lead to uterine rupture in preg-
nancy, intestinal perforation, as well as aortic dilation, dis­section, and rupture. EDS-IV affects about 6% of EDS patients and is the most lethal form of EDS [95].
Shprintzen-Goldberg syndrome (SGS) is another syn­drome with a phenotype similar to LDS and MFS, but the arteriopathy is less severe. SGS phenotypes can include cra­niosynostosis, arachnodactyly, exophthalmos, hypertelorism, maxillary and mandibular hypoplasia, low set ears, abdomi­nal hernias, pectus deformity, scoliosis, Chiari I malforma­tions, and aortic dilation. Functionally, these individuals suffer from developmental delay, mental retardation, and obstructive sleep apnea. These patients can appear to have a Marfanoid habitus [96]. This syndrome is typically inherited in an autosomal dominant pattern, but there must be a caus­ative event that activates the mutation or some germline mosaicism for the mutation to be expressed. Mutations found in the SKI gene appear to cause aortic dilation that can lead to aneurysmal disease. SKI is a SnoN protein that is nor­mally a TGFβ repressor by inhibiting SMAD.SKI competes with a p300/CBP transcription factor for SMAD binding. When SKI binds, it converts chromatin into a repressive state. SKI binds the MH2 domain of the SMAD2/SMAD3 complex, thereby preventing the transcription of TGFβ. However, when it becomes mutated, there is overexpression of TGFβ. The upregulation of TGFβ causes increased signal­ing events, but due to the presence of other repressors of the TGFβ pathway, the vascular phenotype is less severe than that of LDS [97].
Turner’s syndrome (TS) occurs in roughly 1in every 2000 live female births. Characterized by short stature, webbed neck, and premature ovarian failure, these women have nor­mal intelligence. The genotype and phenotype are due to complete or partial monosomy of the X chromosome. The most common causes of early fetal demise or later complica­tions are cardiovascular defects. Babies with in utero fetal demise are typically found to have hypoplastic left heart syn­drome. Common cardiovascular manifestations of TS include bicuspid aortic valves and aortic coarctation [98]. Some develop ascending aortic dilation, dissection, and rup­ture that are not always associated with bicuspid aortic valves.
TS is one of the most common causes for aortic dissection in women. Difculties in diagnosing aortic dilation and pre­dicting rupture may be due in part to the sizing of aortic diameters in short statured women. Adjustment of aortic diameter for height or body surface area indicates signicant aortic dilation in up to 1/3 of women with TS [105]. Two­thirds of TS dissections occur in the ascending aorta (see big­lycan discussion above).
X-linked Alport syndrome is a familial inherited disorder of collagen that affects the alpha-5 chain of type 4 collagen. Type 4 collagen is an important part of basement membranes. This defect affects the glomeruli of the kidneys leading to
40
https://t.me/med1917
T. E. Gaines and L. B. Grimsley
renal brosis as well as the cochlea leading to sensorineural hearing loss. Case reports have identied aortic pathology in males with X-linked Alport syndrome. Most of the cases reported involve dissection in young males between the ages of 20 and 30years. Vascular complications are uncommon in Alport syndrome but arise due to a lack of appropriate pro­collagen trimers in the type 4 collagen bers of lamellar basement membranes in the aortic media. This is caused by the absence of alpha-5 chains [100].
Cutis laxa, or elastolysis, comprises a group of connective tissue elastic ber disorders characterized by loose, redundant skin and may be congenital or acquired. Congenital cutis laxa syndromes present with variable phenotypes and extracutane­ous manifestations including ascending aortic aneurysm, geni­tourinary and gastrointestinal diverticula, diaphragmatic hernia, and emphysema that may lead to cor pulmonale and death in early life. The autosomal dominant form is caused by a defect in ELN that encodes for elastin and has less severe involvement of internal organs and vasculature. Autosomal recessive forms present a more virulent phenotype and are associated with mutations in FBLN4 and FBLN5. An X-linked recessive form, now classied with copper deciency syn­dromes, is caused by a defect in ATP7A [106].
Nonsyndromic FTAADS include a growing number of conditions with identiable mutations as well as aneurysms associated with bicuspid aortic valves. The MYH11 gene and the ACTA2 gene encode for smooth muscle myosin and actin proteins. Both genes encode muscular elements, and the mutations have been thought to be associated with upreg­ulation of TGFβ signaling. MYH11 encodes a smooth muscle myosin heavy chain isoform. The MYH11 gene mutation is associated with a high penetrance of coexistent persistent patent ductus arteriosus. ACTA2 encodes for smooth muscle alpha actin that is also coincidentally expressed during inammation and is a transcriptional target of TGFβ signaling [97].
Moyamoya disease is an occlusive vascular disease asso­ciated with smooth muscle cell proliferation. This disease has incomplete penetrance and is more common in persons of Asian descent. The proliferative arteriopathy in this dis­ease leads to the formation of abnormal collateral vessels in the brain. These arise to compensate for diminished blood ow in narrowed internal carotid arteries. These collateral vessels eventually occlude due to intimal hyperplasia, despite atrophy of the media layer. There also appear to be defects in the elastic lamellae of the arteries as well; however, this is less well characterized [101]. Moyamoya is associated with FTAADS in individuals with ACTA2 mutations [107].
FTAADs have been primarily found through genome sequencing in families with a history of aneurysmal disease. Sequencing reveals deletions and other probable disease causing mutations, as well as variants of unknown signi­cance. Variants of unknown signicance are typically found
in coding regions of known genes for brillin, TGFβ path­way constituents, and SM.While current surgical indications are primarily based on aortic diameter, the association of specic mutations with phenotypes prone to dissection and aneurysm formation will allow more effective risk stratica­tion. Some patients will benet from early prophylactic sur­gery based on their genotype and not size criteria [91].
Bicuspid Aortic Valves
Bicuspid aortic valves (BAV) are the most common congeni­tal cardiac malformation, occurring at a rate of 1–2% [102]. The normal aortic valve consists of three leaets, and bicus­pid valves have two leaets often with a raphe fusing adja­cent, conjoined leaets. Multiple classication systems exist based on the number of raphes, the position of the cusps/ raphes, and the functional status of the valve. One such clas­sication system by Sievers and Schmidtke classied bicus­pid valves based on the number of raphe. Type 0 has no raphe, type 1 has one raphe, and type 2 has two raphes. Type 2 bicuspid valves are associated with the highest incidence of ascending aneurysms according to one study of 304 surgical patients [103]. The formation of ascending aneurysms in BAV patients may be caused by the ow dynamics of blood as it passes through a reduced aortic valve opening. Due to the position of the cusps, a high velocity jet is continuously directed toward the convexity of the ascending aorta, eventu­ally causing dilation and dissection or aneurysm [102, 103]. Russo classied bicuspid valves based on where the fusion of the cusps occurred [104]. Type A valves had fusion of the left and right coronary cusps. Type B valves had fusion of the right and noncoronary cusps, and type C valves had fusion of the left coronary and noncoronary cusps. Russo found that type A cusps were the most common. Type A cusps affected a younger subset of patients with a larger mean aortic root diameter. Based on the histopathology of aortic specimens, type A valves and their associated aortas had a higher preva­lence of brosis, medial necrosis, elastic fragmentation, and inammation compared to type B valves. This study also found a direct correlation between the degree of aortic wall degeneration and the ascending aortic diameter [104].
Patients with bicuspid aortic valves tend to have increased arterial stiffness due to the degradation of elastin bers within the aortic wall. There also appears to be abnormal endothelial cell function with downregulation of endothelial nitric oxide synthase (eNOS). Due to the downregulation of eNOS, nitric oxide bioactivity is increased, which subse­quently increases MMP2 expression. Increased wall stiffness in the aorta is thought to be mediated by multiple factors and cytokines, but specically matrix metalloproteinases like MMP2. These aortas are then remodeled leading to dilation of the aortic walls [102].
3 Pathophysiology ofAscending Aortic Aneurysm andDissection
https://t.me/med1917
41
References
1. Berretta P, etal. IRAD experience on surgical type A acute dissec­tion patients: results and predictors of mortality. Ann Cardiothorac Surg. 2016;5(4):346–51.
2. Howard DP, etal. Population-based study of incidence and out­come of acute aortic dissection and premorbid risk factor con­trol: 10-year results from the Oxford Vascular Study. Circulation. 2013;127(20):2031–7.
3. Shadwick RE. Mechanical design in arteries. J Exp Biol. 1999;202(Pt 23):3305–13.
4. Frank O. Die Grundform des arteriellen pulses. Zeitung fur Biologie. 1899;37:483–526.
5. Stergiopulos N, Westerhof BE, Westerhof N.Total arterial iner­tance as the fourth element of the windkessel model. Am J Phys. 1999;276(1 Pt 2):H81–8.
6. Maksuti E, etal. Contribution of the arterial system and the heart to blood pressure during normal aging- a simulation study. PLoS One. 2016;11(6):e015–7493.
7. Sherratt MJ. Tissue elasticity and the ageing elastic bre. Age (Dordr). 2009;31(4):305–25.
8. Garcia-Herrera CM, etal. Mechanical behaviour and rupture of normal and pathological human ascending aortic wall. Med Biol Eng Comput. 2012;50(6):559–66.
9. Shah SB, etal. Prefailure and failure mechanics of the porcine ascending thoracic aorta: experiments and a multiscale model. J Biomech Eng. 2014;136(2):021028.
10. Guo X, Kassab GS. Variation of mechanical properties along the length of the aorta in C57bl/6 mice. Am J Physiol Heart Circ Physiol. 2003;285(6):H2614–22.
11. Wagenseil JE, Mecham RP.Vascular extracellular matrix and arte­rial mechanics. Physiol Rev. 2009;89(3):957–89.
12. Okamoto RJ, etal. The inuence of mechanical properties on wall stress and distensibility of the dilated ascending aorta. J Thorac Cardiovasc Surg. 2003;126(3):842–50.
13. Dobrin PB. Mechanical properties of arteries. Physiol Rev. 1978;58(2):397–460.
14. Beller CJ, etal. Role of aortic root motion in the pathogenesis of aortic dissection. Circulation. 2004;109(6):763–9.
15. Jager IL.A model for the stability and creep of organic materials. J Biomech. 2005;38(7):1459–67.
16. Chu B, etal. Characterization of fracture toughness exhaustion in pig aorta. J Mech Behav Biomed Mater. 2013;17:126–36.
17. Gunning GM, Murphy BP.Characterisation of the fatigue life, dynamic creep and modes of damage accumulation within mitral valve chordae tendineae. Acta Biomater. 2015;24:193–200.
18. Pfaltzgraff ER, etal. Embryonic domains of the aorta derived from diverse origins exhibit distinct properties that converge into a com­mon phenotype in the adult. J Mol Cell Cardiol. 2014;69:88–96.
19. Jiang X, et al. Fate of the mammalian cardiac neural crest. Development. 2000;127(8):1607–16.
20. Cheung C, et al. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol. 2012;30(2):165–73.
21. Majesky MW.Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol. 2007;27(6):1248–58.
22. Haar JL, Ackerman GA.A phase and electron microscopic study of vasculogenesis and erythropoiesis in the yolk sac of the mouse. Anat Rec. 1971;170(2):199–223.
23. Huber TL, et al. Haemangioblast commitment is initi­ated in the primitive streak of the mouse embryo. Nature. 2004;432(7017):625–30.
24. Kennedy M, etal. Development of the hemangioblast denes the onset of hematopoiesis in human ES cell differentiation cultures. Blood. 2007;109(7):2679–87.
25. Siekmann AF, etal. Chemokine signaling guides regional pattern­ing of the rst embryonic artery. Genes Dev. 2009;23(19):2272–7.
26. Quillien A, et al. Distinct Notch signaling outputs pattern the developing arterial system. Development. 2014;141(7):1544–52.
27. Yamashita J, etal. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408(6808):92–6.
28. Waldo KL, etal. Secondary heart eld contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev Biol. 2005;281(1):78–90.
29. Dyer LA, Kirby ML.The role of secondary heart eld in cardiac development. Dev Biol. 2009;336(2):137–44.
30. Maleki S, etal. Mesenchymal state of intimal cells may explain higher propensity to ascending aortic aneurysm in bicuspid aortic valves. Sci Rep. 2016;6:35712.
31. McDonald OG, etal. Control of SRF binding to CArG box chro­matin regulates smooth muscle gene expression in vivo. J Clin Invest. 2006;116(1):36–48.
32. Oh J, Richardson JA, Olson EN. Requirement of myocardin­related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc Natl Acad Sci U S A. 2005;102(42):15122–7.
33. Pardali E, Ten Dijke P. TGFb signaling and cardiovascular dis­eases. Int J Biol Sci. 2012;8(2):195–213.
34. Kitisin K, et al. Tgf-Beta signaling in development. Sci STKE. 2007;2007(399):cm1.
35. Mu Y, Gudey SK, Landstrom M.Non-Smad signaling pathways. Cell Tissue Res. 2012;347(1):11–20.
36. Lauring J, Park BH, Wolff AC.The phosphoinositide-3-kinase­Akt-mTOR pathway as a therapeutic target in breast cancer. J Natl Compr Cancer Netw. 2013;11(6):670–8.
37. ten Dijke P, Arthur HM. Extracellular control of TGFb signal­ling in vascular development and disease. Nat Rev Mol Cell Biol. 2007;8(11):857–69.
38. Teekakirikul P, etal. Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations. Am J Med Genet A. 2013;161A(1):185–91.
39. Cannaerts E, et al. TGF-beta signalopathies as a paradigm for translational medicine. Eur J Med Genet. 2015;58(12):695–703.
40. Zilberberg L, etal. Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. Proc Natl Acad Sci U S A. 2015;112(45):14012–7.
41. Andelnger G, Loeys B, Dietz H. A decade of discovery in the genetic understanding of thoracic aortic disease. Can J Cardiol. 2016;32(1):13–25.
42. Topouzis S, Majesky MW.Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to trans­forming growth factor-beta. Dev Biol. 1996;178(2):430–45.
43. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals. Deviation of man from the usual pattern. Circ Res. 1969;25(6):677–86.
44. Majesky MW. Adventitia and perivascular cells. Arterioscler Thromb Vasc Biol. 2015;35(8):e31–5.
45. Dingemans KP, etal. Extracellular matrix of the human aortic media: an ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Rec. 2000;258(1):1–14.
46. Majesky MW, etal. The adventitia: a dynamic interface contain­ing resident progenitor cells. Arterioscler Thromb Vasc Biol. 2011;31(7):1530–9.
47. Muiznieks LD, Keeley FW.Molecular assembly and mechanical properties of the extracellular matrix: a brous protein perspec­tive. Biochim Biophys Acta. 2013;1832(7):866–75.
48. Jensen SA, Robertson IB, Handford PA.Dissecting the brillin microbril: structural insights into organization and function. Structure. 2012;20(2):215–25.
49. Sengle G, Sakai LY.The brillin microbril scaffold: a niche for growth factors and mechanosensation? Matrix Biol. 2015;47:3–12.
50. Cecchi A, etal. Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome. Am J Med Genet A. 2013;161A(9):2305–10.
42
https://t.me/med1917
T. E. Gaines and L. B. Grimsley
51. Doyle JJ, et al. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. Elife. 2015:4.
52. Koenders MM, et al. Microscale mechanical properties of sin­gle elastic bers: the role of brillin-microbrils. Biomaterials. 2009;30(13):2425–32.
53. Sherratt MJ, etal. Fibrillin microbrils are stiff reinforcing bres in compliant tissues. J Mol Biol. 2003;332(1):183–93.
54. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic bres. J Cell Sci. 2002;115(Pt 14):2817–28.
55. Merla G, etal. Supravalvular aortic stenosis: elastin arteriopathy. Circ Cardiovasc Genet. 2012;5(6):692–6.
56. Bax DV, etal. Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin alphaVbeta3. J Biol Chem. 2009;284(42):28616–23.
57. Treloar LRG.The physics of rubber elasticity / by L.R.G.Treloar, Oxford classic texts in the physical sciences. 3rd ed. Oxford, NewYork: Clarendon Press; Oxford University Press; 2005. xii, 310 p.
58. Chung J, etal. Energy loss, a novel biomechanical parameter, correlates with aortic aneurysm size and histopathologic nd­ings. J Thorac Cardiovasc Surg. 2014;148(3):1082–8; discussion 1088–9
59. Shalhub S, et al. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes. J Vasc Surg. 2014;60(1):160–9.
60. Jain D, et al. Causes and histopathology of ascending aor­tic disease in children and young adults. Cardiovasc Pathol. 2011;20(1):15–25.
61. Owens GK, Kumar MS, Wamhoff BR.Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84(3):767–801.
62. Karimi A, Milewicz DM.Structure of the elastin-contractile units in the thoracic aorta and how genes that cause thoracic aortic aneurysms and dissections disrupt this structure. Can J Cardiol. 2016;32(1):26–34.
63. Guo DC, etal. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya dis­ease, along with thoracic aortic disease. Am J Hum Genet. 2009;84(5):617–27.
64. Wang L, etal. Mutations in myosin light chain kinase cause famil­ial aortic dissections. Am J Hum Genet. 2010;87(5):701–7.
65. Loeys BL, etal. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355(8):788–98.
66. Chen X, et al. TGF-beta neutralization enhances AngII-induced aortic rupture and aneurysm in both thoracic and abdominal regions. PLoS One. 2016;11(4):e0153811.
67. Lacro RV, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med. 2014;371(22):2061–71.
68. Wang C, et al. Angiotensin II induces an increase in MMP-2 expression in idiopathic ascending aortic aneurysm via AT1 receptor and JNK pathway. Acta Biochim Biophys Sin Shanghai. 2015;47(7):539–47.
69. Nastase MV, Young MF, Schaefer L.Biglycan: a multivalent pro­teoglycan providing structure and signals. J Histochem Cytochem. 2012;60(12):963–75.
70. Schaefer L, Iozzo RV.Biological functions of the small leucine­rich proteoglycans: from genetics to signal transduction. J Biol Chem. 2008;283(31):21305–9.
71. Corsi A, etal. Phenotypic effects of biglycan deciency are linked to collagen bril abnormalities, are synergized by decorin de­ciency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res. 2002;17(7):1180–9.
72. Heegaard AM, et al. Biglycan deciency causes sponta­neous aortic dissection and rupture in mice. Circulation. 2007;115(21):2731–8.
73. Meester JA, etal. Loss-of-function mutations in the X-linked big­lycan gene cause a severe syndromic form of thoracic aortic aneu­rysms and dissections. Genet Med. 2017;19(4):386–95.
74. Geerkens C, et al. The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene. Hum Genet. 1995;96(1):44–52.
75. Carlson M, etal. Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the international turner syndrome aortic dissection regis­try. Circulation. 2012;126(18):2220–6.
76. Hagman A, et al. Morbidity and mortality after childbirth in women with Turner karyotype. Hum Reprod. 2013;28(7):1961–73.
77. Homme JL, et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol. 2006;30(9):1159–68.
78. Dingemans KP, etal. Ultrastructural pathology of aortic dissec­tions in patients with Marfan syndrome: comparison with dissec­tions in patients without Marfan syndrome. Cardiovasc Pathol. 2006;15(4):203–12.
79. Coady MA, et al. Surgical intervention criteria for thoracic aor­tic aneurysms: a study of growth rates and complications. Ann Thorac Surg. 1999;67(6):1922–6; discussion 1953–8.
80. Davies RR, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg. 2002;73(1):17–27; discussion 27–8.
81. Koullias G, et al. Mechanical deterioration underlies malig­nant behavior of aneurysmal human ascending aorta. J Thorac Cardiovasc Surg. 2005;130(3):677–83.
82. Pape LA, etal. Aortic diameter >or = 5.5cm is not a good predic­tor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2007;116(10):1120–7.
83. Paruchuri V, etal. Aortic size distribution in the general popula­tion: explaining the size paradox in aortic dissection. Cardiology. 2015;131(4):265–72.
84. Landenhed M, et al. Risk proles for aortic dissection and rup­tured or surgically treated aneurysms: a prospective cohort study. J Am Heart Assoc. 2015;4(1):e001513.
85. Poullis MP, etal. Ascending aortic curvature as an independent risk factor for type A dissection, and ascending aortic aneurysm formation: a mathematical model. Eur J Cardiothorac Surg. 2008;33(6):995–1001.
86. Kruger T, etal. Ascending aortic elongation and the risk of dissec­tion. Eur J Cardiothorac Surg. 2016;50(2):241–7.
87. Thubrikar MJ, Agali P, Robicsek F.Wall stress as a possible mech­anism for the development of transverse intimal tears in aortic dis­sections. J Med Eng Technol. 1999;23(4):127–34.
88. Fung YC, Fronek K, Patitucci P. Pseudoelasticity of arter­ies and the choice of its mathematical expression. Am J Phys. 1979;237(5):H620–31.
89. Martin C, Sun W, Elefteriades J.Patient-specic nite element analysis of ascending aorta aneurysms. Am J Physiol Heart Circ Physiol. 2015;308(10):H1306–16.
90. Thunes JR, et al. A structural nite element model for lamellar unit of aortic media indicates heterogeneous stress eld after col­lagen recruitment. J Biomech. 2016;49(9):1562–9.
91. Ziganshin BA, Bailey AE, Coons C, Dykas D, et al. Routine genetic testing for thoracic aortic aneurysm and dissection in clin­ical setting. Ann Thorac Surg. 2015;100(5):1604–11.
92. Tsilou E, MacDonald IM. Weill-Marchesani syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. SourceGeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993–2017. 2007 Nov 1 [updated 2013 Feb 14].
93. Loeys-Dietz Syndrome. Genetics Home Reference 2014 12/21/16 [cited 2016 December 25]. Available from: https://ghr.nlm.nih.
gov/condition/loeys-dietz-syndrome#sourcesforpage.
3 Pathophysiology ofAscending Aortic Aneurysm andDissection
https://t.me/med1917
43
94. Loeys BL, Schwarze U, Holm T, Callewaert BL, etal. Aneurysm syndromes caused by mutations in the tgfb receptor. N Engl J Med. 2006;355(8):788–98.
95. Schwartz RA. Ehlers-Danlos Syndrome. Medscape,
2016. Available at:
article/1114004-overview
96. Shprintzen RJ, Goldberg RB. A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias. J Craniofac Genet Dev Biol. 1982;2(1):65–74.
97. Isselbacher EM, Lino Cardenas CL, Lindsay ME. Hereditary inuence in thoracic aortic aneurysms and dissection. Circulation. 2016;133(24):2516–28.
98. Bondy CA. Aortic dissection in Turner syndrome. Curr Opin Cardiol. 2008;23(6):519–26.
99. Renard M, Holm T, Veith R, Callewaert BL, etal. Altered TGFbeta signaling and cardiovascular manifestations in patients with auto­somal recessive cutis laxa type I caused by bulin-4 deciency. Eur J Hum Genet. 2010;18(8):895–901.
100. Kashtan CE, Segal Y, Flinter F, Makanjuola D, Gan JS, Watnick T.Aortic abnormalities in males with Alport syndrome. Nephrol Dial Transplant. 2010;25(11):3554–60.
101. Wetzel-Strong SE, Detter MR, Marchuk DA.The pathobiology of vascular malformations: insights from human and model organ­ism genetics. J Pathol. 2017;241(2):281–93.
102. Tzemos N, Lyseggen E, Silversides C, Jamorski M, Tong JH, Harvey P, Floras J, Siu S. Endothelial function, carotid-fem­oral stiffness, and plasma matrix metalloproteinase-2 in men
https://emedicine.medscape.com/
.
with bicuspid aortic valve and dilated aorta. J Am Coll Cardiol. 2010;55(7):660–8.
103. Sievers HH, Schmidtke C.A classication system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133(5):1226–33.
104. Russo CF, Cannata A, Lanfranconi M, Vitali E, Garatti A, Bonacina E.Is aortic wall degeneration related to bicuspid aor­tic valve anatomy in patients with valvular disease? J Thorac Cardiovasc Surg. 2008;136(4):937–42.
105. Ostberg JE, Brookes JAS, McCarthy C, Halcox J, Conway GS.A comparison of echocardiography and magnetic resonance imag­ing in cardiovascular screening of adults with turner syndrome. J Clin Endocrinol Metab. 2004;89(12):5966–71.
106. Renard M, Holm T, Veith R, Callewaert BL, Adès LC, Baspinar O, Pickart A, Dasouki M, Hoyer J, Rauch A, Trapane P, Earing MG, Coucke PJ, Sakai LY, Dietz HC, De Paepe AM, Loeys BL.Altered TGFβ signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by bulin-4 de­ciency. Eur J Hum Genet. 2010;18(8):895–901.
107. Guo D-C, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS, Estrera AL, Sa HJ, Veeraraghavan S, Muzny DM, Wheeler DA, Willerson JT, Yu RK, Shete SS, Scherer SE, Raman CS, Buja LM, Milewicz DM.Mutations in smooth muscle alpha-actin (ACTA2) cause cor­onary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84(5):617–27.
Pathology of the Aorta: Inflammatory
https://t.me/med1917
and Noninflammatory Conditions Predisposing to Aneurysm Formation, Dissection, and Rupture
Jessica Gulliver and Erin G. Brooks
4
Introduction
The aorta is an elastic artery with a caliber that expands with systole and recoils during diastole. In adults, it extends an average of 490cm in length from thoracic initiation to pelvic bifurcation, and it is anatomically divided into three layers, i.e. the tunica intima, tunica media, and tunica adventitia (Fig. 4.1) [1]. The tunica intima is the layer closest to the aortic lumen and is composed of extracellular matrix proteins and a few multipotent stromal cells [1, 2]. It includes an endo- thelial cell layer and extends to the internal elastic lamina (IEL). The IEL delimits the tunica intima from tunica media and consists of elastic bers that form a barrier between large molecules within the circulating blood (e.g. cholesterol) and the underlying layers of the aortic wall. In newborns, the inti­mal layer is quite thin with the endothelial cells closely approximated to the IEL; with “wear-and-tear” aging, intimal thickness increases due to deposition of extracellular matrix proteins [3]. The tunica media extends to the external elastic lamina (EEL) and is the thickest layer of the aorta. Its compo­nents are concentrically arranged into lamellar units with each lamellar unit being composed of a layer of elastic bers with subjacent smooth muscle cells and some embedded extracellular matrix including collagen bers and ground sub­stance [1, 2]. In newborns, the number of stacked lamellar units is only about 35; however, by adulthood, this has gener­ally increased to 50–60 lamellar units [3]. The tunica adven­titia is the outermost layer of the aortic wall and is composed of connective tissue, adipocytes, lymphatic channels, and the vasa vasorum. Given the width of the aortic wall, a special­ized vascular system is needed to supply oxygen and other nutrients to the parts of the aortic wall furthest from the blood
J. Gulliver (*) Department of Pathology, University of Wisconsin Hospital and Clinics, Madison, WI, USA
E. G. Brooks Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA
owing within the aortic lumen; thus, the vasa vasorum sup­plies oxygen and nutrients to the outer third of the tunica media. Disruption to the normal layers of the aortic wall due to a variety of diseases can result in signicant morbidity and mortality. Thus, familiarity with clinicopathologic features supportive of particular disease processes is advised.
Overview of Aortic Disease
The recent consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology recom­mends that aortic diseases detected in surgical pathology specimens be categorized as either inammatory or nonin­ammatory processes and offers a standardized approach to the processing of specimens, disease grading, and disease nomenclature [3, 4]. It is anticipated that such standardization will result in enhanced understanding of aortic diseases and improved patient care. Either inammatory or noninamma­tory aortic disease may ultimately result in serious sequelae such as aortic aneurysm formation, acute aortic dissection, or aortic rupture. A brief overview of the pathogenesis and epi­demiologic features of aortic aneurysms and aortic dissec­tions is followed by a review of the distinct inammatory and noninammatory disease processes that may lead to such phenomena.
Aortic Aneurysm
Pathologically, a true aortic aneurysm is dened as a local­ized dilatation involving the entire thickness of the wall; it may be congenital or acquired [5]. A false or pseudoaneu­rysm, in contrast, is dened as a ruptured arterial wall in which blood is conned by surrounding tissues forming an extravascular hematoma [5]. In the United States, true tho­racic and abdominal aortic aneurysms represent the 15th leading cause of death in people greater than age 55 and are the 19th overall leading cause of death [6].
© Springer Nature Switzerland AG 2019 R. S. Dieter et al. (eds.), Diseases of the Aorta, https://doi.org/10.1007/978-3-030-11322-3_4
45
46
a
https://t.me/med1917
J. Gulliver and E. G. Brooks
b
c
d
e
f
g
Fig. 4.1 (a) Normal layers of the aortic wall with the tunica intima,
tunica media, and tunica adventitia. (b) There is no medial degeneration present (Alcian Blue/PAS stain). (c) The normal aorta contains elastic bers in an organized pattern (Elastic stain). (d) Organized elastic bers
without any degenerative changes (Movat’s pentachrome stain). (e) Medial degeneration within the aortic wall (arrowhead). (f) Elastic ber fragmentation and loss (arrowheads). (g) Increased extracellular matrix material (arrowheads)
4 Pathology of the Aorta: Inflammatory and Noninflammatory Conditions Predisposing to Aneurysm Formation, Dissection…
https://t.me/med1917
47
Thoracic Aortic Aneurysm
More than 95% of thoracic aortic aneurysms (TAAs) are asymptomatic; the prevalence of clinically silent TAAs is estimated to fall between 0.16% and 0.34% [6]. TAAs are more common in men compared to women [6, 7]. The TAA distribution in 60% occur in the root or ascending aorta, 10% in the arch, 40% in the descending aorta, and 10% in the thoracoabdominal aorta (Fig. 4.2). The inci­dence of TAAs appears to be increasing [6, 7]. There seems to be a genetic component to TAAs with 21% of patients with a TAA having a family member with some sort of aneurysm. Genetic syndromes such as Marfan syndrome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome, and Turner syndrome can have TAAs as part of their clinical manifestations of the genetic abnormality [6]. Other risk factors for development of thoracic aortic aneurysm include aging, systemic hypertension, and bicuspid aortic valve [7].
Histologically, medial degeneration is commonly seen in thoracic aortic aneurysm resections. Medial degenera­tion leads to a weakened aortic wall which predisposes to dilatation and eventual aneurysm formation. Mucoid extra­cellular matrix accumulation, loss of smooth muscle cells with disarray, elastic ber degeneration, and disorderly arrangement are some features of medial degeneration [3,
7]. In patients with Marfan syndrome, mutations in bril-
lin-1 are found. Fibrillin-1 is important to the construction of microbrils in the extracellular matrix. Medial degen­eration is often signicant in patients with Marfan syn­drome [7].
Fig. 4.2 Thoracic Aortic Aneurysm Rupture with hemorrhage (arrow
demonstrating aortic arch rupture). Brachiocephalic Artery, Left Common Carotid Artery, and Left Subclavian Artery are adjacent to area of rupture
Abdominal Aortic Aneurysm
Abdominal aortic aneurysms (AAAs) are more common in occurrence when compared to TAAs; up to 80% of aortic aneurysms occur below the renal arteries [7]. Most are due to atherosclerosis, but other causes such as inammatory aneu­rysm, tuberculous aneurysm, medial degeneration, or infec­tious aneurysm are possible [7]. Risk factors for AAAs include smoking, increasing age, greater height, coronary artery disease, atherosclerosis, hypercholesterolemia, and hypertension [7, 8]. Like thoracic aortic aneurysms, genetics also can play a role in AAAs with 12–19% of those patients having an abdominal aneurysm repair being related to a rst degree relative with an AAA [8]. In addition, patients with Ehlers-Danlos type IV who have a defect in their type III collagen synthesis are at an increased risk of AAA [8].
Atherosclerotic plaques play a role in development of AAAs. Signicant inammatory inltrates including numer­ous macrophages and lymphocytes are common in AAAs which may contribute to extracellular matrix degeneration. Histologically, elastic ber loss, medial smooth muscle cell degeneration, and brosis can be seen. Another common nding is thrombus formation within the aortic lumen asso­ciated with the aneurysm. Enzymes such as collagenase and elastase may be upregulated contributing to aneurysmal dila­tation [7].
Aortic Dissection
Approximately 3/100, 000 persons/year develop an aortic dis­section with a slight male predominance. Risk factors for an aortic dissection include age, inherited genetic connective tis­sue diseases such as Marfan syndrome and Ehlers-Danlos syn­drome, hypertension, aortic valvular disease such as bicuspid aortic valve, trauma, prior aortic operations, and cocaine abuse. The most common symptoms are back, abdominal, or chest pain [9]. An aortic dissection occurs when a tear devel­ops in the intimal layer allowing blood to enter into the tunica media layer creating a true lumen and a false lumen (Figs.4.3,
4.4, and 4.5). In cases related to an intimal tear, 60% occur in
the ascending aorta, 25% in the descending aorta, and 10% in the arch and abdominal aorta [9]. Other causes of aortic dis­section could be bleeding from the vasa vasorum in the tunica adventitia into a weakened tunica media layer.
Aortic dissections are often classied into two types: Stanford Type A which occurs in the ascending aorta and Stanford Type B which originates in the descending aorta [9]. Approximately 60% of patients develop Type A dissec­tions with the incidence peaking between 50–60years of age [9]. In patients with inherited connective tissue diseases, a common histological nding is medial degeneration which is